The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

) has been revised to $11.68 / share. This is a decrease of 21.96% from the prior estimate of $14.97 dated December 3, 2025. The price target is an average of many targets provided by analysts. The ...

The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cross Country Healthcare (CCRN) is a stock that can ...

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside ...

Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.19 per share a year ago.

Rhizome Partners, an investment management company, released its third-quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund generated a 4.8% net loss ...

Cross Country Healthcare has seen a material decline in their share price, down 60% from the high in November 2022 following the travel nurse industry declines. There's likely still more softness ...